Save time, refresh your knowledge, and on-board your colleagues using the resource pages provided here. Check out our drug discovery resources page for a high-level overview of resources available.
-
- Reference
An Introduction to Fragment-Based Drug Discovery (FBDD)
In this minireview, Dr. Romyr Dominique introduces three key concepts in fragment-based drug discovery and shares his favorite articles…8 mins read
-
- Reference
What is an IND? What is a Clinical Hold? Why Do Clinical Holds Happen?
In this article, Dr. Thuy Tran, a CMC Project Leader at Servier, gives us a quick explanation of what…8 mins read
-
- Reference
Practical PK Calculators
This page contains Drug Hunter's practical PK calculators useful for day-to-day drug discovery, including a PK unit converter such…2 mins read
-
- Reference
- Sponsored
Solid Form Strategies for Increasing Oral Bioavailability
Small-molecule drug candidates are increasingly falling “beyond the rule of 5,” making oral administration more challenging. Optimizing a drug’s…4 mins read
-
- Approval Reviews
2022 Drug Approvals
This resource page compiles all of the 2022 drug approvals and our articles on the novel small molecule and…2 mins read
-
- Reference
Phase I Drug Metabolism
This article explains what Phase I drug metabolism is, contains a poster summarizing common enzyme-mediated drug metabolism reactions, and…11 mins read
-
- Approval Reviews
2021 Large Molecule Drug Approvals Review
together with Jen Huen, Naveed Yasin, Becca Burnham, Arathi Chintireddy, and Adrian Parodi This high-level overview of 2021’s novel…2 mins read
-
- Approval Reviews
2021 Small Molecule Drug Approvals Review
We’ll be reviewing 2021’s novel FDA drug approvals in a series of articles, starting with this high-level overview of…3 mins read
-
- Approval Reviews
The Resurgence of Antibody-Drug Conjugates – FDA Approved ADCs and Linker-Payloads
Antibody-drug conjugates (ADCs) have gone through several waves of enthusiasm since being first tested in animal models in the 1960’s. The…3 mins read
RECENT ARTICLES
- Small Molecule Long-Acting Injectables (LAIs) Leading to a Paradigm Shift in HIV Treatment and Prophylaxis
- Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q1
- Production-Scale Synthesis of gem-Dimethylcyclopropylproline
- Drug Discovery IPOs in 2022Q1
- AICs and PAINS: Mechanisms of Assay Interference
- Review of 2021 FDA-Approved Drugs for Genetic Conditions
DRUG DISCOVERY RESOURCES
- Drug Discovery Resources
- Drug Discovery Posters and Cheat Sheets
- Drug Discovery IPOs and Industry Reviews
- Lists of Approved Drugs
- Classics in Drug Discovery
- Drug Discovery Books
- Drug Discovery Conferences
- What is a Drug Hunter?
- Topliss Tree and Topliss Scheme Posters
- PK Reference Table / Cheat Sheet
- Pd-Couplings Table / Cheat Sheet
- Phase I Drug Metabolism
- Approved Covalent Drug Mechanisms
- Why LogD Matters / LogD Poster
- Types of Kinase Inhibitors
- Unusual Molecular Interactions from the PDB
- Bioactivation of Structural Alerts
- The Square Cube Law
- Don’t Work on Things That Don’t Work
- What is a Biologic Drug Anyway?
- Managing Liver Injury (DILI) Risk
- Where Do Hits Come From?
JOIN SUBSCRIBERS from
- Johnson & Johnson
- Roche
- Pfizer
- Novartis
- Bayer
- Merck
- Sanofi
- GlaxoSmithKline
- AbbVie
- Eli Lilly
- Boehringer Ingelheim
- Amgen
- Bristol-Myers Squibb
- Gilead
- AstraZeneca
- Teva
- Novo Nordisk
- Merck KGaA
- Takeda
- Celgene (BMS)
- Biogen
- Astellas
- Daiichi Sankyo
- Regeneron
- UCB
- Eisai
- Servier
- Kyowa Kirin
- Shionogi
- Vertex
- Lundbeck
- Taisho
- Ono
- Seagen
- Incyte
- LEO Pharma
- Janssen
- Galapagos
- Idorsia
- Astex
- Arvinas
- Kymera
- Relay
- Schrodinger
- Mirati
- Revolution
- Nimbus
- Plexxikon
- Forma
- Arcus
- RA Capital
- ARCH Venture Partners
- MPM Capital
- Orbimed
- The Column Group
- 5AM Ventures
- Versant Ventures
- Deerfield
- Goldman Sachs
- Citi
- Piper Sandler
- Softbank
- …and hundreds of others